Long Non-Coding RNAs in Drug Resistance of Gastric Cancer: Complex Mechanisms and Potential Clinical Applications

Xiangyu Meng,Xiao Bai,Angting Ke,Kaiqiang Li,Yun Lei,Siqi Ding,Dongqiu Dai
DOI: https://doi.org/10.3390/biom14060608
IF: 6.064
2024-05-23
Biomolecules
Abstract:Gastric cancer (GC) ranks as the third most prevalent malignancy and a leading cause of cancer-related mortality worldwide. However, the majority of patients with GC are diagnosed at an advanced stage, highlighting the urgent need for effective perioperative and postoperative chemotherapy to prevent relapse and metastasis. The current treatment strategies have limited overall efficacy because of intrinsic or acquired drug resistance. Recent evidence suggests that dysregulated long non-coding RNAs (lncRNAs) play a significant role in mediating drug resistance in GC. Therefore, there is an imperative to explore novel molecular mechanisms underlying drug resistance in order to overcome this challenging issue. With advancements in deep transcriptome sequencing technology, lncRNAs—once considered transcriptional noise—have garnered widespread attention as potential regulators of carcinogenesis, including tumor cell proliferation, metastasis, and sensitivity to chemo- or radiotherapy through multiple regulatory mechanisms. In light of these findings, we aim to review the mechanisms by which lncRNAs contribute to drug therapy resistance in GC with the goal of providing new insights and breakthroughs toward overcoming this formidable obstacle.
biochemistry & molecular biology
What problem does this paper attempt to address?
### What problem does this paper attempt to solve? This paper aims to explore the complex mechanisms of long non-coding RNAs (lncRNAs) in drug resistance of gastric cancer (GC) and their potential clinical applications. Specifically: 1. **Background Issues**: - Gastric cancer is the third most common malignancy worldwide and one of the leading causes of cancer-related deaths. - Most patients are diagnosed with gastric cancer at an advanced stage, necessitating effective perioperative and postoperative chemotherapy to prevent recurrence and metastasis. - Current treatment strategies are limited in overall efficacy due to intrinsic or acquired drug resistance. 2. **Research Objectives**: - Investigate the mechanisms by which lncRNAs contribute to drug resistance in gastric cancer to overcome this challenge. - Review how lncRNAs lead to drug treatment resistance and provide new insights and breakthroughs. ### Summary of the main content of the paper 1. **Introduction**: - Emphasizes the high incidence and mortality rates of gastric cancer. - Points out the limited effectiveness of existing treatment methods (such as chemotherapy), with drug resistance being the main obstacle. - Mentions that recent advances in deep sequencing technology have made lncRNAs a research hotspot. 2. **Overview of lncRNAs**: - Explains the basic definition, classification, and functions of lncRNAs. - Describes the important roles of lncRNAs in various biological processes, including cell differentiation, chromatin remodeling, and modification. 3. **Drug Resistance-Related lncRNAs and Their Malignant Phenotypes**: - Lists multiple drug resistance-related lncRNAs and their functions in detail. - Analyzes the mechanisms by which these lncRNAs influence gastric cancer metastasis, proliferation, and apoptosis. 4. **Mechanisms of Action of Drug Resistance-Related lncRNAs**: - Discusses the mechanisms by which lncRNAs regulate drug resistance through various pathways, including the regulation of apoptosis, autophagy, and ferroptosis. Through the above content, this paper attempts to reveal the complex mechanisms of lncRNAs in drug resistance of gastric cancer, providing new ideas and breakthroughs for future research and clinical applications.